Can I do ibogaine while on methadone?

Not directly. Methadone's long half-life means it can remain in tissue for many days, and combining a long-acting opioid agonist with ibogaine complicates the treatment. The standard clinical approach is to first taper to short-acting opioids for a defined period under medical supervision, then complete pre-treatment cardiac screening, and only then proceed with ibogaine.

Is ibogaine a replacement for methadone maintenance?

It's an alternative model, not a replacement. Ibogaine aims to interrupt dependence; methadone aims to stabilize it. Some guests use ibogaine to exit long-term MAT; others use methadone as a bridge if ibogaine is medically contraindicated. The right answer depends on the individual's clinical picture and goals.

What are the long-term outcomes after ibogaine vs staying on methadone?

Published observational data on ibogaine (Brown & Alper, 2018; Davis et al., 2020) shows meaningful reductions in opioid use at 12 months in patients who complete the full protocol including integration. Methadone maintenance outcomes are well-documented at the population level and show clear reductions in overdose mortality while patients remain in treatment. Neither modality achieves 'cure' in isolation — integration, environment, and continued care matter more than the initial intervention in both cases.

Ibogaine vs Methadone | Sanctuary Tulum

The choice between ibogaine and methadone represents two fundamentally different philosophies of treating opioid use disorder. Methadone maintenance is designed to stabilize the opioid receptor system for years or decades. Ibogaine-assisted detox is designed to interrupt physiological dependence in a matter of days. Neither is universally superior — but understanding the mechanisms, evidence, and clinical trade-offs is essential for anyone weighing the two.

How Methadone Maintenance Works

Methadone is a long-acting, full mu-opioid agonist introduced into clinical use in the 1960s. It occupies the same receptors as heroin, fentanyl, or oxycodone, but with a half-life of 24-36 hours it produces a stable plasma level rather than the euphoric peaks-and-crashes cycle of short-acting opioids. Patients on adequate doses typically report suppressed cravings, no withdrawal, and no euphoria. The trade-off is that methadone is itself a physical dependence — discontinuing it produces a protracted withdrawal syndrome that can last several weeks and, in tapering practice, months. SAMHSA and WHO both classify medication-assisted treatment (MAT) as the standard of care in most Western systems, and the epidemiological data supporting reduced overdose mortality on MAT is unambiguous.

How Ibogaine-Assisted Detox Works

Ibogaine is a naturally occurring alkaloid from the root bark of Tabernanthe iboga. Unlike methadone, ibogaine is not a mu-opioid agonist. Its mechanism appears to involve NMDA receptor antagonism, kappa-opioid modulation, sigma-2 binding, and — critically for opioid dependence — resetting of dysregulated receptor signaling. In clinical practice, a single ibogaine treatment session compresses what would be days to weeks of withdrawal into roughly 24-36 hours, with post-treatment craving typically substantially reduced (Mash et al., 2018; Brown & Alper, 2018). Guests emerge physically detoxified from short-acting opioids, though psychological work continues afterward.

Timeline: Days vs Years

The most stark difference is temporal. A guest arriving with fentanyl dependence begins ibogaine work within days of a full medical workup and typically completes the core physiological interruption inside a single treatment window. By contrast, methadone protocols are designed for indefinite duration — the National Institute on Drug Abuse (NIDA) explicitly notes that most patients benefit from at least 12 months of MAT, and many remain on maintenance for life. Neither model is 'faster' in a moral sense; they are answering different questions. Ibogaine asks: can we return the receptor system to baseline? Methadone asks: can we stabilize the receptor system indefinitely?

Safety and Screening: Non-Interchangeable Requirements

Ibogaine has a real cardiac safety profile — specifically hERG channel binding that prolongs the QT interval. This is why every serious ibogaine program requires a pre-treatment EKG, electrolyte panel (potassium and magnesium), liver function testing, and on-site continuous cardiac monitoring during the treatment window. Methadone's safety profile is different: it is chronically safe at stable dose, but overdose risk exists during induction and in combination with benzodiazepines or alcohol. See our ibogaine safety guide and cardiac screening protocol.

Which Model Suits Which Patient

Methadone maintenance is often the correct clinical choice for patients with unstable housing, severe co-occurring illness that precludes intensive interventions, or a personal preference for long-term pharmacological stabilization. Ibogaine-assisted detox — combined with a comprehensive holistic protocol — is better suited to patients whose goal is to be free of daily medication and whose medical picture supports the pre-treatment workup. Many guests at Sanctuary Tulum arrive after years of MAT wanting to complete a supervised transition off methadone; others arrive directly from active fentanyl or oxycodone dependence. Both pathways are clinically valid. Explore our ibogaine fentanyl detox protocol and full opioid recovery program.